Invention Application
- Patent Title: PIPERIDINE-SUBSTITUTED MNK INHIBITORS AND METHODS RELATED THERETO
-
Application No.: US17396187Application Date: 2021-08-06
-
Publication No.: US20220096472A1Publication Date: 2022-03-31
- Inventor: Justin T. Ernst , Paul A. Sprengeler , Siegfried H. Reich , Samuel Sperry
- Applicant: eFFECTOR Therapeutics Inc.
- Applicant Address: US CA San Diego
- Assignee: eFFECTOR Therapeutics Inc.
- Current Assignee: eFFECTOR Therapeutics Inc.
- Current Assignee Address: US CA San Diego
- Main IPC: A61K31/506
- IPC: A61K31/506 ; A61P29/00 ; A61P35/02
Abstract:
The present invention relates to compounds according to Formula (I): or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof wherein X1, X2, R1, R2, R3 and n are as defined herein. Also described are pharmaceutically acceptable compositions of Formula (I) compounds as well as methods for utilizing the compounds of Formula (I) and the pharmaceutically acceptable compositions of Formula (I) compounds as inhibitors of Mnk as well as therapeutics for the treatment of diseases such as cancer.
Public/Granted literature
- US11878015B2 Piperidine-substituted Mnk inhibitors and methods related thereto Public/Granted day:2024-01-23
Information query
IPC分类:
